A critical analysis of the (near) legendary status of vitamin D

References

• Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of Type 1 diabetes: a birth-cohort study. Lancet358, 1500–1503 (2001).
   PubMed Web of Science ®Google Scholar
• Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in Type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab.92, 2017–2029 (2007).
   PubMed Web of Science ®Google Scholar
• Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Simvastatin does not affect vitamin D status, but low vitamin D levels are associated with dyslipidemia: Results from a randomised, controlled trial. Int. J. Endocrinol.2010, 957174 (2010).
   PubMedGoogle Scholar
• Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third national health and nutrition examination survey. Am. J. Hypertens.20, 713–719 (2007).
   PubMed Web of Science ®Google Scholar
• Gross C, Stamey T, Hancock S, Feldman D. Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). J. Urol.159, 2035–2039 (1998).
   PubMed Web of Science ®Google Scholar
• Beer TM, Ryan CW, Venner PM et al. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators. J. Clin. Oncol.25, 669–674 (2007).
   PubMed Web of Science ®Google Scholar
• Mellanby E. An experimental investigation on rickets. Lancet1, 407–412 (1919).
   Google Scholar
• Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J. Clin. Endocrinol. Metab.89, 5387–5391 (2004).
   PubMed Web of Science ®Google Scholar
• Mortensen BM, Gautvik KM, Gordeladze JO. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3. Biosci. Rep.13, 27–39 (1993).
   PubMed Web of Science ®Google Scholar
• Bikle DD, Halloran BP, Whitney JO, Hollis BW. Measurement of 25,26-dihydroxyvitamin D: importance of the configuration of the C-25 hydroxyl group. Biochemistry23, 6920–6925 (1984).
   PubMedGoogle Scholar
• Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S. 25-hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science277, 1827–1830 (1997).
   PubMed Web of Science ®Google Scholar
• Sawada N, Sakaki T, Ohta M, Inouye K. Metabolism of vitamin D(3) by human CYP27A1. Biochem. Biophys. Res. Commun.273, 977–984 (2000).
   PubMed Web of Science ®Google Scholar
• Henry HL. Vitamin D hydroxylase. J. Cell. Biochem.49, 4–9 (1992).
   PubMed Web of Science ®Google Scholar
• Nebert DW, Gonzales FJ. P450 genes: structure, evolution and regulation. Ann. Rev. Biochem.56, 945–993 (1987).
   PubMed Web of Science ®Google Scholar
• Gupta RP, Hollis BW, Patel SB, Patrick KS. CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J. Bone Miner. Res.19, 680–688 (2004).
   PubMed Web of Science ®Google Scholar
• Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J. Biol. Chem.278, 38084–38093 (2003).
   PubMed Web of Science ®Google Scholar
• Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. USA101, 7711–7715 (2004).
   PubMed Web of Science ®Google Scholar
• Shinkyo R, Sakaki T, Kamakura M, Ohta M, Inouye K. Metabolism of vitamin D by human microsomal CYP2R1. Biochem. Biophys. Res. Commun.324, 451–457 (2004).
   PubMed Web of Science ®Google Scholar
• Heaney RP, Armas LAG, Shary JR, Bell NH, Binkley N, Hollis BW. 25-hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am. J. Clin. Nutr.87, 1738–1742 (2008).
   PubMed Web of Science ®Google Scholar
• Shepard RM, Deluca HF. Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes. Arch. Biochem. Biophys.202, 43–53 (1980).
   PubMedGoogle Scholar
• Tanaka Y, DeLuca HF. Rat renal 25-hydroxyvitamin D3 1- and 24-hydroxylases: their in vivo regulation. Am. J. Physiol.246, E168–E173 (1984).
   PubMed Web of Science ®Google Scholar
• Deluca HF, Prahl JM, Plum LA. 1,25-dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D. Arch. Biochem. Biophys.505, 226–230 (2011).
   PubMed Web of Science ®Google Scholar
• Chen TC, Persons K, Uskokovic MR, Horst RL, Holick MF. An evaluation of 1,25-dihydroxyvitamin D3 analogues on the proliferation an differentiation of cultured human keratinocytes, calcium metabolism and the differentiation of human HL-60 cells. J. Nutr. Biochem.4, 49–57 (1993).
   Google Scholar
• Holick MF. Vitamin D deficiency. N. Engl. J. Med.357, 266–281 (2007).
   PubMed Web of Science ®Google Scholar
• IOM (Institute of Medicine). Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press, DC, USA (2011).
   Google Scholar
• Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet351, 805–806 (1998).
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dietrich T, Orav EJ et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged >60 y. Am. J. Clin. Nutr.80, 752–758 (2004).
   PubMed Web of Science ®Google Scholar
• Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am. J. Clin. Nutr.80(Suppl.), S1706–S1709 (2004).
   PubMed Web of Science ®Google Scholar
• Gaugris S, Heaney RP, Boonen S et al. Vitamin D inadequacy among postmenopausal women: a systematic review. OJM98, 557–676 (2005).
   Google Scholar
• Bischoff-Ferrari HA, Willett WC, Wong JB et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA293, 2257–2264 (2005).
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine society clinical practice guideline. J. Clin. Endocrin. Metab.9, 1911–1930 (2011).
   Google Scholar
• Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM. High prevalence of vitamin D insufficiency in black and white women residing in the northern United States and their neonates. J. Nutr.137, 447–452 (2007).
   PubMed Web of Science ®Google Scholar
• Hollis BW. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am. J. Clin. Nutr.80, 1752S–1758S (2004).
   PubMed Web of Science ®Google Scholar
• Omdahl JL, Bobrovinkova EA, Choe S, Dwivedi PP, May BK. Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway. Steroids66, 381–389 (2001).
   PubMed Web of Science ®Google Scholar
• Lissner D, Mason RS, Posen S. Stability of vitamin D metabolites in human blood serum and plasma. Clin. Chem.27, 773–774 (1981).
   PubMed Web of Science ®Google Scholar
• Yates AM, Bowron A, Calton L et al. Interlaboratory variation in 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 is significantly improved if common calibration material is used. Clin. Chem.54, 2082–2084 (2008).
   PubMed Web of Science ®Google Scholar
• Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann. Clin. Biochem.45, 153–159 (2008).
   PubMed Web of Science ®Google Scholar
• Tai SSC, Bedner M, Phinney KW. Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using Isotope-dilution liquid chromatography-tandem mass spectrometry. Anal. Chem.82, 1942–1948 (2010).
   PubMedGoogle Scholar
• Stockl D, Sluss PM, Thienpont LM. Specifications for trueness and precision of a reference measurement system for serum/plasma 25-hydroxyvitamin D analysis. Clin. Chim. Acta408, 8–13 (2009).
   PubMedGoogle Scholar
• Cooke NE, Haddad JG. Vitamin D binding protein (Gc-globulin). Endocrinol. Rev.10, 294–307 (1989).
   PubMed Web of Science ®Google Scholar
• Sadafi FF, Thornton P, Magiera H et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J. Clin. Invest.103, 239–251 (1999).
   PubMedGoogle Scholar
• McLeod JF, Cooke NE. The vitamin D-binding protein, α-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues. J. Biol. Chem.264, 21760–21769 (1989).
   PubMedGoogle Scholar
• Birn H, Fyfe JC, Jacobsen C et al. Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. Clin. Invest.105, 1353–1361 (2000).
   Google Scholar
• Adams JS, Chen H, Chun RF et al. Novel regulators of vitamin D action and metabolism: lessons learned at the Los Angeles zoo. J. Cell. Biochem.88, 308–314 (2003).
   PubMedGoogle Scholar
• Mangelsdorf DJ, Thummel C, Beato M et al. The nuclear receptor superfamily: the second decade. Cell83, 835–839 (1995).
   PubMed Web of Science ®Google Scholar
• Freedman LP, Luisi BF, Korszun ZR, Basavappa R, Sigler PB, Yamamoto KR. The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature334, 543–546 (1988).
   PubMed Web of Science ®Google Scholar
• Norman AW, Adams D, Collins ED, Okamura WH, Fletterick RJ. Three-dimensional model of the ligand binding domain of the nuclear receptor for 1α,25-dihydroxy-vitamin D3. J. Cell. Biochem.74, 323–333 (1999).
   PubMedGoogle Scholar
• Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell.5, 173–179 (2000).
   PubMed Web of Science ®Google Scholar
• Wrange O, Eriksson P, Perlmann T. The purified activated glucocorticoid receptor is a homodimer. J. Biol. Chem.264, 5253–5259 (1989).
   PubMed Web of Science ®Google Scholar
• Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J.13, 5370–5382 (1994).
   PubMed Web of Science ®Google Scholar
• Staal A, van Wijnen AJ, Birkenhäger JC et al. Distinct conformations of vitamin D receptor/retinoid X receptor-α heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol. Endocrinol.10, 1444–1456 (1996).
   PubMedGoogle Scholar
• Stern M, Jensen R, Herskowitz I. Five SWI genes are required for expression of the HO gene in yeast. J. Mol. Biol.178, 853–868 (1984).
   PubMed Web of Science ®Google Scholar
• Rachez C, Gamble M, Chang CP, Atkins GB, Lazar MA, Freedman LP. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol. Cell Biol.20, 2718–2726 (2000).
   PubMed Web of Science ®Google Scholar
• Chen D, Huang SM, Stallcup MR. Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. J. Biol. Chem.275, 40810–40816 (2000).
   PubMedGoogle Scholar
• Dupret JM, Brun P, Thomasset M. In vivo effects of transcriptional and translational inhibitors on duodenal vitamin D-dependent calcium-binding protein messenger ribonucleic acid stimulation by 1,25-dihydroxycholecalciferol. Endocrinology119, 2476–2483 (1986).
   PubMedGoogle Scholar
• Sánchez-Martínez R, Zambrano A, Castillo AI, Aranda A. Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. Mol. Cell. Biol.28, 3817–3829 (2008).
   PubMedGoogle Scholar
• Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C. VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J.14, 1455–1463 (2000).
   PubMed Web of Science ®Google Scholar
• Arbelle JE, Chen H, Gaead MA, Allegretto EA, Pike JW, Adams JS. Inhibition of vitamin D receptor-retinoid X receptor-vitamin D response element complex formation by nuclear extracts of vitamin D-resistant New World primate cells. Endocrinology137, 786–789 (1996).
   PubMedGoogle Scholar
• Chen H, Hu B, Allegretto EA, Adams JS. The vitamin D response element-binding protein: a novel dominant-negative regulator of vitamin D-directed transactivation. J. Biol. Chem.275, 35557–35564 (2000).
   PubMedGoogle Scholar
• Nelson HD, Helfand M, Woolf SH, Aallan JD. Screening for postmenopausal osteoposoris: a review of the evidence for the U.S. preventive services task force. Ann. Intern. Med.137, 529–541 (2002).
   PubMed Web of Science ®Google Scholar
• Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos. Int.20, 315–322 (2009).
   PubMed Web of Science ®Google Scholar
• Meyer HE, Smedshaug GB, Kvaavik E, Falch JA, Tverdal A, Pedersen JI. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J. Bone Miner. Res.17, 709–715 (2002).
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Willett WC, Wong JB et al. Prevention of nonvertebral fractures with oral vitamin D dose dependency. A meta-analysis of randomized controlled trials. Arch. Intern. Med.169, 551–561 (2009).
   PubMed Web of Science ®Google Scholar
• Graafmans WC, Ooms ME, Hofstee HM, Bezemer PD, Bouter LM, Lips P. Falls in elderly: a prospective study of risk factor and risk profiles. Am. J. Epidemiol.143, 1129–1136 (1996).
   PubMed Web of Science ®Google Scholar
• Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J. Bone Miner. Res.15, 1113–1118 (2000).
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Stahelin HB, Dick W et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J. Bone Miner. Res.18, 343–351 (2003).
   PubMedGoogle Scholar
• Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J. Am. Geriatr. Soc.55, 234–239 (2007).
   PubMed Web of Science ®Google Scholar
• Priemel M, von Domarus C, Klatte TO et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J. Bone Miner. Res.25, 305–312 (2010).
   PubMed Web of Science ®Google Scholar
• Need AG. Bone resorption markers in vitamin D insufficiency. Clin. Chim. Acta368, 48–52 (2006).
   PubMed Web of Science ®Google Scholar
• van Driel M, Koedam M, Buurman CJ et al. Evidence for auto/paracrine actions of vitamin D in bone: 1α-hydroxylase expression and activity in human bone cells. FASEB J.20, 2417–2419 (2006).
   PubMed Web of Science ®Google Scholar
• Atkins GJ, Anderson PH, Findlay DM et al. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 α,25-dihydroxyvitamin D3. Bone40, 1517–1528 (2007).
   PubMedGoogle Scholar
• Horwood NJ, Elliott J, Martin TJ, Gillespie MT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology139, 4743–4746 (1998).
   PubMedGoogle Scholar
• Kogawa M, Findlay DM, Anderson PH et al. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption. Endocrinology151, 4613–4625 (2010).
   PubMed Web of Science ®Google Scholar
• Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H et al. Rituximab, B-lymphocyte depletion, and preservation of β-cell function. N. Engl. J. Med.361, 2143–2152 (2009).
   PubMed Web of Science ®Google Scholar
• MacLaughlin JA, Anderson RR, Holick MF. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its isomers in human skin. Science216, 1001–1003 (1982).
   PubMed Web of Science ®Google Scholar
• Webb AR, Kline L, Holilck MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J. Clin. Endocrinol. Metab.67, 373–378 (1988).
   PubMed Web of Science ®Google Scholar
• Staples JA, Ponsonby AL, Lim LL, McMichael AJ. Ecologic analysis of some immune-related disorders, including Type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ. Health Perspect.111, 518–523 (2003).
   PubMed Web of Science ®Google Scholar
• Kimlin MG, Olds WJ, Moore MR. Location and vitamin D synthesis: is the hypothesis validated by geophysical data? J. Photochem. Photobiol.B.86, 234–239 (2007).
   Google Scholar
• Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of Type 1 diabetes in 51 regions worldwide. Diabetologia51, 1391–1398 (2008).
   PubMed Web of Science ®Google Scholar
• Fronczak CM, Barón AE, Chase HP et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabet. Care26, 3237–3242 (2003).
   PubMedGoogle Scholar
• The EURODIAB substudy 2 study group. Vitamin D supplement in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus. Diabetologia42, 51–54 (1999).
   PubMed Web of Science ®Google Scholar
• Stene Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia43, 1093–1098 (2000).
   PubMedGoogle Scholar
• Crinò A, Di Stasio E, Manfrini S et al. The effects of calcitriol and nicotinamide on residual pancreatic β-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet. Med.23, 920–923 (2006).
   PubMedGoogle Scholar
• Illig T, Bongardt F, Schöpfer A et al. Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with Type 2 diabetes. J. Clin. Endocrinol. Metab.89, 5053–5058 (2004).
   PubMed Web of Science ®Google Scholar
• Fernández-Real JM, Vendrell J, Ricart W et al. Polymorphism of the tumor necrosis factor- α receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated Type 2 diabetic patients. Diabet. Care23, 831–837 (2000).
   PubMed Web of Science ®Google Scholar
• Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1α,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes51, 1367–1374 (2002).
   PubMed Web of Science ®Google Scholar
• Riachy R, Vandewalle B, Belaich S et al. Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets. J. Endocrinol.169, 161–168 (2001).
   PubMed Web of Science ®Google Scholar
• Christakos S, Norman AW. Studies on the mode of action of calciferol XVIII-evidence for a specific high affinity binding protein for 1,25-dihydroxyvitamin D3 in chick kidney and pancreas. Biochem. Biophys. Res. Commun.89, 56–63 (1979).
   PubMedGoogle Scholar
• Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science209, 823–825 (1980).
   PubMed Web of Science ®Google Scholar
• Milner RD, Hales CN. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia3, 47–49 (1967).
   PubMedGoogle Scholar
• Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia38, 1239–1245 (1995).
   PubMed Web of Science ®Google Scholar
• Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia29, 142–145 (1986).
   PubMed Web of Science ®Google Scholar
• Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am. J. Clin. Nutr.59, 1083–1087 (1994).
   PubMed Web of Science ®Google Scholar
• Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and β-cell dysfunction. Am. J. Clin. Nutr.79, 820–825 (2004).
   PubMed Web of Science ®Google Scholar
• Sanchez M, de la Sierra A, Coca A, Poch E, Giner V, Urbano-Marquez A. Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension29, 531–536 (1997).
   PubMedGoogle Scholar
• Harris MI, Flegal KM, Cowie CC et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988–1994. Diabet. Care21, 518–524 (1998).
   PubMed Web of Science ®Google Scholar
• Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabet. Care27, 2813–2818 (2004).
   PubMed Web of Science ®Google Scholar
• Need AG, O’Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin. Endocrinol. (Oxf.)62, 738–741 (2005).
   PubMed Web of Science ®Google Scholar
• Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabet. Care28, 1228–1230 (2005).
   PubMed Web of Science ®Google Scholar
• Avenell A, Cook JA, MacLennan GS, McPherson GC. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing38, 606–609 (2009).
   PubMedGoogle Scholar
• Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T. Effect of 1 α (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner.1, 187–192 (1986).
   PubMedGoogle Scholar
• Ljunghall S, Lind L, Lithell H et al. Treatment with one-α-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance – a prospective randomized double-blind study. Acta Med. Scand.222, 361–363 (1987).
   PubMedGoogle Scholar
• Stumpf WE, Sar M, Reid FA et al. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science206, 1188–1190 (1979).
   PubMed Web of Science ®Google Scholar
• Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res.1, 191–195 (1941).
   Google Scholar
• Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of cancer-ready for prime time? N. Engl. J. Med.364, 1385–1387 (2011).
   PubMed Web of Science ®Google Scholar
• Speers C, Brown P. Breast cancer prevention using calcium and vitamin D: a bright future? J. Natl Cancer Inst.100, 1562–1564 (2008).
   PubMedGoogle Scholar
• Heaney RP, Lappe JM. Reply to MM Sood and AR Sood. Am. J. Clin. Nutr.86, 1549–1550 (2007).
   PubMedGoogle Scholar
• Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer. Cancer Causes Cont.15, 149–158 (2004).
   PubMed Web of Science ®Google Scholar
• Colli JL, Colli A. International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. Urol. Oncol.24, 184–194 (2006).
   PubMed Web of Science ®Google Scholar
• Grant WB. A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. Eur. Urol.45, 271–279 (2004).
   PubMed Web of Science ®Google Scholar
• Luscombe CJ, Fryer AA, French ME et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet258, 641–642 (2001).
   Google Scholar
• Frazier AL, Li L, Cho E, Willett WC, Colditz GA. Adolescent diet and risk of breast cancer. Cancer Causes Cont.15, 73–82 (2004).
   PubMed Web of Science ®Google Scholar
• McCullough ML, Rodriguez C, Diver WR et al. Dairy, calcium and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II nutrition cohort. Cancer Epidemiol. Biomarkers Prev.14, 2898–2904 (2005).
   PubMed Web of Science ®Google Scholar
• Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC. Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J. Natl Cancer Inst.94, 1301–1311 (2002).
   PubMed Web of Science ®Google Scholar
• Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R. Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol. Biomarkers Prev.16, 422–429 (2007).
   PubMed Web of Science ®Google Scholar
• Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to induced differentiation of the myelomonocytic cell line U937. Genes Dev.10, 142–153 (1996).
   PubMed Web of Science ®Google Scholar
• Norman AW, Bishop JE, Bula CM et al. Molecular tools for study of genomic and rapid signal transduction responses initiated by 1α25(OH)2-vitamin D3. Steroids67, 457–466 (2002).
   PubMedGoogle Scholar
• Hager G, Kornfehl J, Knerer B, Weigel G, Formanek M. Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs. Acta Otolaryngol.124, 90–96 (2004).
   PubMed Web of Science ®Google Scholar
• van der Kerkhof PCM. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br. J. Dermatol.132, 675–682 (1995).
   PubMedGoogle Scholar
• Koli K, Keekj-Oja J. 1 α,25(OH)2D3 and its analogs down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ.11, 221–229 (2000).
   PubMedGoogle Scholar
• Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1α,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ. Res.87, 214–220 (2000).
   PubMed Web of Science ®Google Scholar
• Elias J, Marian B, Edling C et al. Induction of apoptosis by vitamin D metabolites and analogs in a glioma cell line. Recent Results Cancer Res.164, 319–332 (2003).
   PubMedGoogle Scholar
• Tangpricha V, Spina C, Yao M, Chen TC, Wolfe MM, Holick MF. Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J. Nutr.135, 2350–2354 (2005).
   PubMed Web of Science ®Google Scholar
• Fu GK, Lin D, Zhang MY et al. Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets Type 1. Mol. Endocrinol.11, 1961–1970 (1997).
   PubMed Web of Science ®Google Scholar
• Ritchie HH, Hughes MR, Thompson ET et al. An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families. Proc. Natl Acad. Sci. USA86, 9783–9787 (1989).
   PubMedGoogle Scholar
• McDonnell DP, Scott RA, Kerner SA, O’Malley BW, Pike JW. Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression. Mol. Endocrinol.3, 635–644 (1989).
   PubMedGoogle Scholar
• Sone T, Marx SJ, Liberman UA, Pike JW. A unique point mutation in the human vitamin D receptor chromosomal gene confers hereditary resistance to 1,25-dihydroxyvitamin D3. Mol. Endocrinol.4, 623–631 (1990).
   PubMedGoogle Scholar
• Saijo T, Ito M, Takeda E et al. A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am. J. Hum. Genet.49, 668–673 (1991).
   PubMed Web of Science ®Google Scholar
• Hirst MA, Hochman HI, Feldman D. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. J. Clin. Endocrinol. Metab.60, 490–495 (1985).
   PubMedGoogle Scholar
• Rut AR, Hewison M, Kristjansson K, Luisi B, Hughes MR, O’Riordan JL. Two mutations causing vitamin D resistant rickets: modeling on the basis of steroid hormone receptor DNA-binding domain crystal structures. Clin. Endocrinol. (Oxf.).41, 581–590 (1994).
   PubMedGoogle Scholar
• McKay HA, Bailey DA, Wilkinson AA, Houston CS. Familial comparison of bone mineral density at the proximal femur and lumbar spine. Bone Miner.24, 95–107 (1994).
   PubMedGoogle Scholar
• Slemendda CW, Christian JC, Williams CJ, Norton JA, Johnston CC Jr. Genetic determinants of bone mass in adult women: a reevaluation of the twin model, and the potential importance of gene interaction on heritability estimates. J. Bone Miner. Res.6, 561–567 (1991).
   PubMedGoogle Scholar
• Arai H, Miyamoto KI, Yoshida M et al. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J. Bone Miner. Res.16, 1256–1264 (2001).
   PubMed Web of Science ®Google Scholar
• Fang Y, van Meurs JB, Bergink AP et al. Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J. Bone Miner. Res.18, 1632–1641 (2003).
   PubMed Web of Science ®Google Scholar
• Liel Y, Shany S, Smirnoff P, Schwartz B. Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology140, 280–285 (1999).
   PubMed Web of Science ®Google Scholar
• Uitterlinden AG, Ralston SH, Brandi ML et al. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann. Intern. Med.145, 255–264 (2006).
   PubMed Web of Science ®Google Scholar
• Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc. Natl Acad. Sci. USA89, 6665–6669 (1992).
   PubMed Web of Science ®Google Scholar
• Faraco JH, Morrison NA, Baker A, Shine J, Frossard PM. ApaI dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Res.17, 2150–2157 (1989).
   PubMedGoogle Scholar
• Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature367, 284–287 (1994).
   PubMed Web of Science ®Google Scholar
• Inagaki K, Krall EA, Fleet JC, Garcia RI. Vitamin D receptor alleles, periodontal disease progression, and tooth loss in the VA dental longitudinal study. J. Periodontol.74, 161–167 (2003).
   PubMed Web of Science ®Google Scholar
• Wang C, Zhao H, Xiao L et al. Association between vitamin D receptor gene polymorphisms and severe chronic periodontitis in a Chinese population. J. Periodontol.80, 603–608 (2009).
   PubMed Web of Science ®Google Scholar
• Yoshihara A, Sugita N, Yamamoto K, Kobayashi T, Miyazaki H, Yoshi H. Analysis of vitamin D and Fc γ receptor polymorphisms in Japanese patients with generalized early-onset periodontitis. J. Dent. Res.80, 2051–2054 (2001).
   PubMedGoogle Scholar
• de Brito Júnior RB, Scarel-Caminaga RM, Trevilatto PC, de Souza AP, Barros SP. Polymorphisms in the vitamin D receptor gene are associated with periodontal disease. J. Periodontol.75, 1090–1095 (2004).
   PubMed Web of Science ®Google Scholar
• Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, Sweeney C. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol. Biomarkers Prev.16, 2752–2755 (2007).
   PubMed Web of Science ®Google Scholar
• Sweeney C, Curtin K, Murtaugh MA, Caan BJ, Potter JD, Slattery ML. Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol. Biomarkers Prev.15, 744–749 (2006).
   PubMed Web of Science ®Google Scholar
• Guy M, Lowe LC, Bretherton-Watt D et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin. Cancer Res.10, 5472–5481 (2004).
   PubMed Web of Science ®Google Scholar
• Li H, Stampfer MJ, Hollis JB et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med.4, e103 (2007).
   PubMed Web of Science ®Google Scholar
• Arai H, Miyamoto K, Taketani Y et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J. Bone Miner. Res.12, 915–921 (1997).
   PubMed Web of Science ®Google Scholar
• Ruggiero M, Pacini S, Aterini S, Fallai C, Ruggiero C, Pacini P. Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. Oncol. Res.10, 43–46 (1998).
   PubMedGoogle Scholar
• Lowe LC, Guy M, Mansi JL et al. Plasma 25-hydroxyvitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur. J. Cancer41, 1164–1169 (2005).
   PubMed Web of Science ®Google Scholar
• English DR, Armstrong BK, Kricker A, Fleming C. Sunlight and cancer. Cancer Causes Cont.8, 271–283 (1997).
   PubMed Web of Science ®Google Scholar
• Hutchinson PE, Osborne JE, Lear JT et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin. Cancer Res.2, 498–504 (2000).
   Google Scholar
• Shulman AI, Larson C, Mangelsdorf DJ, Ranganathan R. Structural determinants of allosteric ligand activation in RXR heterodimers. Cell116, 417–429 (2004).
   PubMed Web of Science ®Google Scholar
• Li J, Wang J, Wang J et al. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J.19, 4342–4350 (2000).
   PubMed Web of Science ®Google Scholar
• Fischle W, Dequiedt F, Hendzel MJ et al. Enzymatic activity associated with Class 2 HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell.9, 45–57 (2002).
   PubMed Web of Science ®Google Scholar
• Rachez C, Freedman LP. Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene246, 9–21 (2000).
   PubMed Web of Science ®Google Scholar
• Banwell CM, MacCartney DP, Guy M et al. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin. Cancer Res.12, 2004–2013 (2006).
   PubMed Web of Science ®Google Scholar
• Collins FS, Morgan M, Patrinos A. The human genome project: lessons from large-scale biology. Science300, 286–290 (2003).
   PubMed Web of Science ®Google Scholar
• Gross C, Eccleshall TR, Malloy PJ, Luz M. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican–American women. J. Bone Miner. Res.11, 1850–1855 (1996).
   PubMed Web of Science ®Google Scholar
• Mortial A, Iki M, Dohi Y et al. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese women. Int. J. Epidemiol.33, 979–988 (2004).
   PubMedGoogle Scholar